刊名:The Chinese-German Journal of Clinical Oncology
出版年:2008
出版时间:February 2008
年:2008
卷:7
期:2
页码:75-77
全文大小:140KB
参考文献:1. Xing CP, Liu B, Dong L. The criterion of immunohistochemistry. Chin J Pathol (Chinese), 2001, 30: 318. 2. Jacobs TW, Gown AM, Yaziji H, / et al. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol, 1999, 17: 1983鈥?987. 3. Lai C, Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron, 1991, 6: 691鈥?04. CrossRef 4. Plowman GD, Culouscou JM, Whitney GS, / et al. Ligand-specific activation of HER4/P180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA, 1993, 90: 1746鈥?750. CrossRef 5. Srinivasan R, Poulsom R, Hurst HC, / et al. Expression of the c-erbB4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol, 1998, 185: 236鈥?45. CrossRef 6. Bonnet H, Filhol O, Truchet I, / et al. Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J Biol Chem, 1996, 271: 24781鈥?4787. CrossRef 7. Li W, Park JW, Nuijens A, / et al. Heregulin is rapidly translocated to the nucleus and its transprot is correlated with c-myc induction in breast cancer cells. Oncogene, 1996, 12: 2473鈥?477. 8. al Moustafa AE, Alaoui-Jamali M, Paterson J, / et al. Expression of P185erbB-2, P160ERBb-3, P180erbB-4, and Heregulin alpha in human normal bronchial epithelial and lung cancer cell lines. Anticancer Res, 1999, 19: 481鈥?86.
作者单位:Zaichun Deng (1) Wenying Yu (1) Guoping Hu (1) Ruheng Zheng (2) Dunhua Zhang (2) Yunshan Tan (2) Yonghua Xu (3) Wanli Jiang (3)
1. The Affiliated Hospital of Ningbo University, Ningbo, 315020, China 2. Zhongshan Hospital, Fudan University, Shanghai, 200032, China 3. Shanghai Institute of Cellular Biology, Chinese Academy of Sciences, Shanghai, 200032, China
文摘
Objective To test the expression of HER4 in non-small cell lung cancer (NSCLC) and elucidate the relationship between its over-expression and the clinical pathology of NSCLC. Methods 70 cases of paraffin-embedded tissues from informative NSCLC were tested for the expression of HER4 by means of immunohistochemical assay. Results HER4 were overexpressed in NSCLC in 91.4%. The overexpression of HER4 correlated only with the lymph node metastasis, TNM staging and survival after operation. Conclusion ErbB4 is one of the genes to regulate the growth of NSCLC in advanced stages and artificial interference of the overexpression of HER4 in NSCLC might be a good way for the treatment of NSCLC in advanced stages.